Cargando…
Evaluating antitumor activity of Escherichia coli purine nucleoside phosphorylase against head and neck patient‐derived xenografts
BACKGROUND: Purine nucleoside phosphorylase (PNP) gene transfer represents a promising approach to treatment of head and neck malignancies. We tested recombinant adenovirus already in phase I/II clinical testing and leading‐edge patient‐derived xenografts (PDX) as a means to optimize this therapeuti...
Autores principales: | Rab, Regina, Ehrhardt, Annette, Achyut, Bhagelu R., Joshi, Disha, Gilbert‐Ross, Melissa, Huang, Chunzi, Floyd, Katharine, Borovjagin, Anton V., Parker, William B., Sorscher, Eric J., Hong, Jeong S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939994/ https://www.ncbi.nlm.nih.gov/pubmed/36253876 http://dx.doi.org/10.1002/cnr2.1708 |
Ejemplares similares
-
Effect of expression of adenine phosphoribosyltransferase on the in vivo anti-tumor activity of prodrugs activated by E. coli purine nucleoside phosphorylase
por: Parker, W B, et al.
Publicado: (2011) -
Purine nucleoside phosphorylase is associated with centrioles and basal bodies
Publicado: (1981) -
Conservation of structure and activity in Plasmodium purine nucleoside phosphorylases
por: Chaikuad, Apirat, et al.
Publicado: (2009) -
Purine nucleoside phosphorylase deficiency in two unrelated Saudi patients
por: Alangari, Abdullah, et al.
Publicado: (2009) -
Antitumor effects of a dual-specific lentiviral vector carrying the Escherichia coli purine nucleoside phosphorylase gene
por: Wang, Xiaolong, et al.
Publicado: (2017)